A recent article from Tech Times discusses the effects of a new reversal agent for the drug Pradaxa on patients suffering from a brain hemorrhage. It is important to note these are brain hemorrhages caused by the drug Pradaxa, which is a relatively new type of anticoagulant medication.
When patients take Pradaxa, we now know there is a significant risk they they will develop a serious internal bleeding disorder than includes possible intracranial bleeding, which is also known as brain hemorrhage. There is no known way to determine which patients will develop the serious bleeding disorder, as risk factors are not known in the event that there are any. Continue reading